This announcement is a separate document:
千红制药:董事会审计委员会对会计师事务所2023年度履职情况评估及履行监督职责情况的报告
Changzhou Qianhong Biopharma: Report of the Audit Committee of the Board of Directors on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.